Virtus Investment Advisers’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $447K | Buy |
3,555
+722
| +25% | +$90.7K | 0.15% | 199 |
|
|
2025
Q1 | $313K | Sell |
2,833
-1,152
| -29% | -$127K | 0.09% | 238 |
|
|
2024
Q4 | $544K | Hold |
3,985
| – | – | 0.43% | 71 |
|
|
2024
Q3 | $459K | Hold |
3,985
| – | – | 0.36% | 90 |
|
|
2024
Q2 | $549K | Hold |
3,985
| – | – | 0.46% | 65 |
|
|
2024
Q1 | $550K | Hold |
3,985
| – | – | 0.39% | 74 |
|
|
2023
Q4 | $525K | Buy |
3,985
+1,604
| +67% | +$211K | 0.39% | 73 |
|
|
2023
Q3 | $268K | Buy |
+2,381
| New | +$268K | 0.18% | 137 |
|